What Happened

A 60-year-old Florida pharmacist and pharmacy owner was sentenced to 90 months in prison for illegally dispensing more than 300,000 oxycodone 30mg pills to pharmacy patrons who had no medical need for the drug.

The pharmacist owned and operated two pharmacies, one in Margate and one in Pembroke Pines, and distributed oxycodone 30mg through both. According to court documents and trial evidence, she dispensed oxycodone to nearly all of her customers, charged them approximately 10 times the typical cost of the drug, and required cash payment. In total she dispensed at least 335,351 oxycodone 30mg pills during the conspiracy. Oxycodone 30mg is the maximum strength available and is typically prescribed to seriously ill patients, such as those with chronic cancer pain or traumatic injuries.

Customers drove long distances to have her fill prescriptions they could not get filled at any other pharmacy, and some paid as much as $1,300 a month in cash. Some customers were drug dealers who picked up oxycodone purportedly on behalf of dozens of patients at a time who were not present. Witnesses testified that she kept the pharmacy doors locked during business hours and directed employees to open them only for certain identified customers. She continued dispensing this way after repeated warnings from her own employees and from the DEA.

After a two-week trial in July 2026, a jury convicted her of conspiracy to illegally distribute drugs and five counts of illegal drug distribution. She was sentenced on October 29, 2026. A co-defendant pleaded guilty to conspiracy to illegally distribute drugs and is scheduled to be sentenced later this year. DEA, the FBI, and HHS-OIG investigated the case.

What Went Wrong

This was not theft from inventory. A registrant used her own pharmacies to move maximum-strength oxycodone to people with no medical need, and the warning signs were visible to staff, to DEA, and in the dispensing data itself:

  • Corresponding responsibility ignored. A pharmacist has an independent duty to ensure a controlled substance prescription is issued for a legitimate medical purpose. Dispensing oxycodone 30mg to nearly every customer is the opposite of that duty.
  • Classic pill-mill red flags. Cash-only payment, prices about 10 times typical, customers traveling long distances, and prescriptions no other pharmacy would fill are all well-recognized indicators of illegitimate dispensing.
  • Third-party pickups for absent patients. Releasing pills to individuals collecting for dozens of patients at a time who were not present removed any meaningful check on who received the drug.
  • Restricted physical access. Locking the doors during business hours and admitting only identified customers signaled an operation built around a specific clientele rather than a community pharmacy.
  • Warnings did not stop the conduct. Employees and DEA both raised concerns repeatedly. Because the person responsible for compliance was the owner, internal escalation had nowhere to go.

How It Could Have Been Prevented

  • Apply corresponding responsibility at every fill: verify the prescriber, the patient, and the medical purpose, and refuse prescriptions that cannot be resolved.
  • Monitor dispensing data for the share of customers receiving high-strength opioids, cash-pay rates, unusual pricing, and patients traveling long distances. Treat these as red flags that need review.
  • Require patient identification at pickup and limit or document third-party pickups, especially for one person collecting for many patients.
  • Give employees an escalation path outside the pharmacy's ownership, such as the state board of pharmacy or DEA, so staff concerns about dispensing practices are not handled only by the owner.
  • Distributors and wholesalers should watch for ordering patterns concentrated in oxycodone 30mg and investigate suspicious orders before shipping.

Related Guidance

Sources